Trial Profile
A Randomized, Control, Open-label, Multicenter, Phase II/III Studies of Chlorogenic Acid for Injection for Safety and Efficacy of Grade IV GBM Patients
Status:
Recruiting
Phase of Trial:
Phase II/III
Latest Information Update: 05 May 2021
Price :
$35
*
At a glance
- Drugs Chlorogenic acid (Primary) ; Lomustine
- Indications Glioblastoma
- Focus Registrational; Therapeutic Use
- Sponsors Sichuan J.Z. Bio-chemical Science and Technology Development Co
- 07 Dec 2018 New trial record